PharmaShots | Incisive News in 3 Shots

Subscribe Now

Secondary Progressive

Novartis' Mayzent Receives Health Canada's Approval for Secondary Progressive Multiple Sclerosis with Active Disease

Novartis' Mayzent Receives Health Canada's Approval for Secondary Progressive Multiple Sclerosis with Active Disease

March 3, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us